Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU New Approach consultation closes:

This article was originally published in Clinica

Executive Summary

The European Commission's consultation on the New Approach directives, which include the medical devices directives, closes at the end of this month. The exercise has been designed to include the maximum number of stakeholders and interested parties. Comments received in April have not been taken into account in this version of the document, but will be taken on board for the preparation of the legal text, says the United Kingdom Accreditation Service (UKAS). Information on the review of the New Approach and a questionnaire has been posted at: http//ec.europa/enterprise/newapproach/review-en.htm. The results will be made available, inter alia, at www.ukas.com * UKAS' new guide, "Who is doing your calibration work?" explaining the importance of ensuring that suppliers of calibration services are accredited to international standard ISO/IEC 17025:2005 is now available at the above website (www.UKAS.com)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052444

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel